Calcitonin Receptor (CALCR) is a Class B (secretin) G protein-coupled receptor (GPCR) that binds calcitonin, calcitonin gene-related peptide (CGRP), amylin, and related peptides. While primarily studied in bone metabolism and migraine, CALCR is increasingly recognized for its roles in neuroprotection, pain modulation, and neuroinflammatory processes relevant to Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions [1](https://doi.org/10.1016/j.pneurobio.2019.04.004). The receptor is encoded by the [CALCR](/genes/calcr) gene and signals through multiple G protein pathways to regulate diverse physiological processes in the central and peripheral nervous systems.
Calcitonin Receptor (CALCR) is a Class B (secretin) G protein-coupled receptor (GPCR) that binds calcitonin, calcitonin gene-related peptide (CGRP), amylin, and related peptides. While primarily studied in bone metabolism and migraine, CALCR is increasingly recognized for its roles in neuroprotection, pain modulation, and neuroinflammatory processes relevant to Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions [1](https://doi.org/10.1016/j.pneurobio.2019.04.004). The receptor is encoded by the [CALCR](/genes/calcr) gene and signals through multiple G protein pathways to regulate diverse physiological processes in the central and peripheral nervous systems.
The CALCR protein possesses the characteristic architecture of Class B GPCRs, consisting of distinct domains optimized for peptide hormone binding and signal transduction [10](https://doi.org/10.1124/pr.119.018531).
N-terminal Extracellular Domain (ECD): The large ECD (approximately 150 amino acids) contains multiple disulfide bonds and a conserved fold that serves as the primary ligand-binding site. This domain recognizes the C-terminal region of peptide ligands including calcitonin, CGRP, and amylin. The ECD adopts a unique fold characterized by a short α-helix and a β-hairpin, creating a binding pocket that achieves high-affinity ligand recognition through a network of hydrogen bonds and hydrophobic interactions.
Seven Transmembrane Domain (TMD): Like other GPCRs, CALCR contains seven transmembrane helices (TM1-TM7) connected by three extracellular loops (ECL1-3) and three intracellular loops (ICL1-3). The transmembrane domain adopts the classic seven-helix bundle conformation that undergoes conformational changes upon ligand binding, enabling coupling to intracellular G proteins. The Class B signature includes a conserved proline in TM6 and specific residues in the DRY motif at the boundary of TM3 and ICL2.
C-terminal Intracellular Domain: The C-terminal tail (approximately 80 amino acids) contains serine/threonine residues that serve as phosphorylation sites for GPCR kinases (GRKs). This domain also contains motifs important for receptor internalization and desensitization through β-arrestin recruitment.
Ligand-Binding Pocket Architecture
The ligand-binding mechanism involves two distinct binding sites:
Primary Binding Site (ECD): The extracellular domain provides the primary high-affinity binding interface for peptide ligands. Structural studies have revealed that the C-terminal "message" region of CGRP engages the ECD, while the N-terminal region interacts with the transmembrane domain to trigger signal transduction.
Secondary Binding Site (TMD): The transmembrane domain contributes to ligand recognition, particularly for small molecule antagonists (gepants). The interface between the ECD and TMD creates a complex binding pocket that can be targeted by different drug classes.
Post-translational Modifications
CALCR undergoes several important post-translational modifications:
N-linked Glycosylation: The extracellular domain contains multiple N-glycosylation sites that affect receptor folding, trafficking, and ligand-binding affinity
Disulfide Bonds: Conserved disulfide bonds in the ECD maintain structural stability
Palmitoylation: C-terminal cysteine residues undergo S-acylation, anchoring the receptor in the plasma membrane
Normal Physiological Function
Signaling Pathways
CALCR activates multiple intracellular signaling cascades through coupling to different G protein subtypes [8](https://doi.org/10.1016/j.celrep.2022.110123):
Promotes PKA activation and downstream phosphorylation events
Mediates bone resorption inhibition (calcitonin) and neuromodulation (CGRP)
Gq/11-coupled PLC/IP3/DAG Pathway
Activates phospholipase C (PLC)
Generates inositol trisphosphate (IP3) and diacylglycerol (DAG)
Increases intracellular calcium release
Involved in pain signaling and vasodilation
Gβγ-mediated Pathways
Activates PI3K/Akt signaling
Modulates ion channel function
Contributes to neuroprotective effects
β-arrestin Signaling
Independent of G protein signaling
Mediates receptor internalization
Activates MAPK pathways (ERK1/2, p38)
Tissue Distribution and Function
Nervous System
In the central nervous system, CALCR (particularly as the CGRP receptor complex) is expressed in regions involved in pain processing, mood, and autonomic function:
Trigeminal Nucleus Caudalis: Primary site for processing craniofacial pain
Hypothalamus: Regulates stress responses and autonomic function
Locus Coeruleus: Modulates arousal and pain perception
Periaqueductal Gray: Involved in descending pain inhibition
Hippocampus: Expressed in CA1/CA3 regions, implicated in memory
These therapeutics block the CALCR-RAMP1 complex, preventing CGRP binding and subsequent signal transduction, thereby terminating migraine attacks or reducing their frequency.
Alzheimer's Disease
Emerging evidence links CALCR/CGRP signaling to AD pathophysiology [6](https://doi.org/10.3233/JAD-191234):
CGRP Expression: Altered CGRP levels in AD patient CSF and brain tissue
Neuroprotective Effects: CGRP promotes neuronal survival through cAMP/PKA and PI3K/Akt pathways [9](https://doi.org/10.1016/j.neuropharm.2021.01.023)
Amyloid Interaction: CGRP may modulate amyloid-beta production and aggregation
Synaptic Function: CGRP signaling affects synaptic plasticity and memory
Calcium Homeostasis: CALCR-mediated calcium signaling is dysregulated in AD
Neuroinflammation: CGRP modulates microglial activation and cytokine release [13](https://doi.org/10.1002/glia.23812)
Parkinson's Disease
CALCR has been implicated in PD through several mechanisms [15](https://doi.org/10.1002/mds.28456):
Dopaminergic Neurons: CALCR is expressed in substantia nigra pars compacta neurons
Neuroprotection: CGRP can protect dopaminergic neurons from oxidative stress
Neuroinflammation: Modulates microglial activation in the substantia nigra
Motor Function: CALCR signaling affects basal ganglia circuits
Therapeutic Potential: CALCR agonists may slow dopaminergic degeneration
Other Neurodegenerative Conditions
Amyotrophic Lateral Sclerosis (ALS): CGRP levels altered in patient CSF; CALCR expressed in motor neurons
Multiple Sclerosis: CGRP modulates demyelination and neuroinflammation
Frontotemporal Dementia: CALCR involvement in tau pathology
Huntington's Disease: CGRP signaling affects medium spiny neuron survival
Protein-Protein Interactions
Coreceptor Complexes
RAMP1 (Receptor Activity Modifying Protein 1): Essential for forming functional CGRP receptor; changes receptor pharmacology and trafficking
RAMP2: Forms AM (adrenomedullin) receptor
RAMP3: Forms AM2/AMY2 receptor
Signaling Partners
Gs protein: Couples to cAMP production
Gq/11 protein: Couples to PLC signaling
β-arrestin 1/2: Mediates internalization and G protein-independent signaling
Associated Proteins
CGRP (CALCA gene product): Primary ligand
Amylin (IAPP gene product): Alternate ligand
Receptorchesterin (RAMP1): Accessory protein
Animal Models
Transgenic Models
| Model | Description | Phenotype | Relevance | |-------|-------------|-----------|-----------| | CALCR knockout mice | Germline CALCR deletion | Bone turnover, pain behavior | Receptor function | | RAMP1 knockout mice | Lacks CGRP receptor | Migraine resistance | CGRP biology | | CALCR floxed mice | Conditional deletion | Tissue-specific knockout | CNS function | | Human CALCR knock-in | Human CALCR expression | Rescue of knockout | Drug testing |